The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A hierarchical clustering approach to dissect behavioral symptoms in early-stage breast cancer (BC).
 
Martina Pagliuca
Travel, Accommodations, Expenses - Gilead Sciences
 
Pietro Lapidari
Travel, Accommodations, Expenses - Lilly
 
Leonor Fasse
Employment - GlaxoSmithKline
Consulting or Advisory Role - Pierre Fabre
Research Funding - Amgen; GlaxoSmithKline
 
Diane Boinon
Honoraria - MSD
 
Marianne Hermand-Deslandes
No Relationships to Disclose
 
Anne-Laure Martin
No Relationships to Disclose
 
Dominique Delmas
No Relationships to Disclose
 
Christelle Jouannaud
Honoraria - Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Pfizer
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca
Travel, Accommodations, Expenses - MSD Oncology; Viatris
 
Marion Fournier
No Relationships to Disclose
 
Laurence Vanlemmens
No Relationships to Disclose
 
Coureche Kaderbhai
No Relationships to Disclose
 
Anne Kieffer
No Relationships to Disclose
 
Baptiste Sauterey
No Relationships to Disclose
 
François Cherifi
Honoraria - Gilead, Pharmaand, MSD,ROCHE Astrazeneca
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Gilead, Pharmaand, MSD,ROCHE Astrazeneca, Chugai
 
Florence Lerebours
Consulting or Advisory Role - AstraZeneca; Eisai; Gilead Sciences; Lilly; Menarini; Novartis; Roche; Seagen
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche; Seagen
 
Michelino De Laurentiis
Stock and Other Ownership Interests - Arvinas
Honoraria - AstraZeneca; Daiichi Sankyo Europe GmbH; Exact Sciences; Gilead Sciences; Ipsen; Lilly; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagen; TOMA Biosciences; Veracyte
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo Europe GmbH; Gilead Sciences; Ipsen; Lilly; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
Speakers' Bureau - Novartis
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Genzyme (Inst); Lilly; MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
 
Stefan Michiels
Consulting or Advisory Role - Biophytis; IQvia; Kedrion Biopharma; Roche; SERVIER; Yuhan
 
Maria Alice Franzoi
Speakers' Bureau - Novartis (Inst)
Research Funding - Gilead Sciences (Inst); Resilience Care (Inst); Resilience Care (Inst)
 
Ines Luis
Honoraria - AstraZeneca (Inst); Chugai Pharma (Inst); Institut de recherches internationales Servier (Inst); Novartis (Inst); Sandoz; Servier Monde (Inst)
Research Funding - Resilience Care (Inst)
Travel, Accommodations, Expenses - Novartis; Novartis
 
Antonio Di Meglio
Expert Testimony - Kephren; techspert.io